Subscribe
charnsitr-shutterstock-com-apple-logo-
12 December 2016Patents

Federal Circuit affirms PTAB invalidation of VirnetX patents

The US Court of Appeals for the Federal Circuit has affirmed decisions by the US Patent and Trademark Office in three patent disputes between licensing company VirnetX and Apple over network technology.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
Apple ordered to pay $439m for infringing VirnetX patents
17 October 2017   Apple has been ordered to pay more than $439 million to internet security software company VirnetX, after again being found liable for patent infringement relating to its ‘FaceTime’ technology.


Editor's picks

Ferrari wins Testarossa classic car case at EU court
Trademarks
Ferrari wins Testarossa classic car case at EU court
2 July 2025

Editor's picks

Trademarks
Ferrari wins Testarossa classic car case at EU court
2 July 2025
Patents
A step too far? Why Stewart’s approach is dividing opinion
20 June 2025
AI
What is an ‘AI training declaration’ and who might need one?
20 June 2025
Future of IP
‘Sad beige’ lawsuit shows how hard it is for influencers to stand out
20 June 2025
Trademarks
Creative licence: Inside the LEGO Group’s Asia playbook
16 June 2025
Copyright
‘Cynical and bewildering’: UK omits copyright protections in Data Bill
13 June 2025

More articles

Lord Justice Birss to become chancellor of the High Court
‘We created law’: G1/24 and the creation of the ‘diamond standard’
Tech litigators join Hogan Lovells’ Paris practice from A&O Shearman
How in-house patent pros are ‘enablers of innovation’
Smart IP for startups: how to avoid the common traps
Defending the realm: How a key MoD supplier crafts its IP strategy
How IP firms can champion LGBTQ+ staff beyond Pride 2025
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations